This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a thiazolidinedione moiety, makes it valuable in the design of molecules targeting metabolic disorders such as diabetes. It has been explored for its potential role in modulating peroxisome proliferator-activated receptors (PPARs), which are involved in glucose and lipid metabolism. Additionally, it serves as a key intermediate in the preparation of biologically active compounds with anti-inflammatory, antioxidant, and anticancer properties. Its application extends to organic synthesis, where it is utilized to create heterocyclic compounds with diverse therapeutic potentials.